Magnetic hyperthermia therapy in glioblastoma tumor on-a-Chip model
Authors:
- Javier Bustamante MamaniJMJavier Bustamante Mamani
- Bruna Souto MarinhoBMBruna Souto Marinho
- Gabriel Nery de Albuquerque RegoGRGabriel Nery de Albuquerque Rego
- Mariana Penteado NucciMariana Penteado Nucci
- Fernando AlvieriFAFernando Alvieri
- Ricardo Silva dos SantosRSRicardo Silva dos Santos
- João Victor Matias FerreiraJFJoão Victor Matias Ferreira
- Fernando Anselmo de OliveiraFernando Anselmo de Oliveira
- Lionel Fernel GamarraLionel Fernel Gamarra
Open Access
- 20 December 2019
- journal article
- research article
- Published by Sociedade Beneficente Israelita Brasileira Hospital Albert Einstein in Einstein (São Paulo)
- Vol. 18, eAO4954
Abstract
To evaluate the magnetic hyperthermia therapy in glioblastoma tumor-on-a-Chip model using a microfluidics device. The magnetic nanoparticles coated with aminosilane were used for the therapy of magnetic hyperthermia, being evaluated the specific absorption rate of the magnetic nanoparticles at 300 Gauss and 305kHz. A preculture of C6 cells was performed before the 3D cells culture on the chip. The process of magnetic hyperthermia on the Chip was performed after administration of 20μL of magnetic nanoparticles (10mgFe/mL) using the parameters that generated the specific absorption rate value. The efficacy of magnetic hyperthermia therapy was evaluated by using the cell viability test through the following fluorescence staining: calcein acetoxymethyl ester (492/513nm), for live cells, and ethidium homodimer-1 (526/619nm) for dead cells dyes. Magnetic nanoparticles when submitted to the alternating magnetic field (300 Gauss and 305kHz) produced a mean value of the specific absorption rate of 115.4±6.0W/g. The 3D culture of C6 cells evaluated by light field microscopy imaging showed the proliferation and morphology of the cells prior to the application of magnetic hyperthermia therapy. Fluorescence images showed decreased viability of cultured cells in organ-on-a-Chip by 20% and 100% after 10 and 30 minutes of the magnetic hyperthermia therapy application respectively. The study showed that the therapeutic process of magnetic hyperthermia in the glioblastoma on-a-chip model was effective to produce the total cell lise after 30 minutes of therapy.Keywords
This publication has 37 references indexed in Scilit:
- The big picture on nanomedicine: the state of investigational and approved nanomedicine productsNanomedicine: Nanotechnology, Biology and Medicine, 2013
- Nanomaterials for (Nano)medicineACS Medicinal Chemistry Letters, 2012
- Laser and radiofrequency-induced hyperthermia treatment via gold-coated magnetic nanocompositesInternational Journal of Nanomedicine, 2011
- Efficacy and safety of intratumoral thermotherapy using magnetic iron-oxide nanoparticles combined with external beam radiotherapy on patients with recurrent glioblastoma multiformeJournal of Neuro-Oncology, 2010
- Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomasJournal of Neuro-Oncology, 2009
- Post-mortem studies in glioblastoma patients treated with thermotherapy using magnetic nanoparticlesBiomaterials, 2009
- Intracranial Thermotherapy using Magnetic Nanoparticles Combined with External Beam Radiotherapy: Results of a Feasibility Study on Patients with Glioblastoma MultiformeJournal of Neuro-Oncology, 2006
- The effect of thermotherapy using magnetic nanoparticles on rat malignant gliomaJournal of Neuro-Oncology, 2005
- Rat C6 glioma as experimental model system for the study of glioblastoma growth and invasionCell and tissue research, 2002
- Intracellular Hyperthermia for Cancer Using Magnetite Cationic Liposomes: In vitro StudyJapanese Journal of Cancer Research, 1996